These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18177995)

  • 1. Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist.
    Mersereau JE; Levy N; Staub RE; Baggett S; Zogovic T; Chow S; Ricke WA; Tagliaferri M; Cohen I; Bjeldanes LF; Leitman DC
    Mol Cell Endocrinol; 2008 Feb; 283(1-2):49-57. PubMed ID: 18177995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract.
    Cvoro A; Paruthiyil S; Jones JO; Tzagarakis-Foster C; Clegg NJ; Tatomer D; Medina RT; Tagliaferri M; Schaufele F; Scanlan TS; Diamond MI; Cohen I; Leitman DC
    Endocrinology; 2007 Feb; 148(2):538-47. PubMed ID: 17095596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Licorice root components in dietary supplements are selective estrogen receptor modulators with a spectrum of estrogenic and anti-estrogenic activities.
    Boonmuen N; Gong P; Ali Z; Chittiboyina AG; Khan I; Doerge DR; Helferich WG; Carlson KE; Martin T; Piyachaturawat P; Katzenellenbogen JA; Katzenellenbogen BS
    Steroids; 2016 Jan; 105():42-9. PubMed ID: 26631549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MF101: a multi-component botanical selective estrogen receptor beta modulator for the treatment of menopausal vasomotor symptoms.
    Leitman DC; Christians U
    Expert Opin Investig Drugs; 2012 Jul; 21(7):1031-42. PubMed ID: 22616988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The estrogen receptor beta agonist liquiritigenin enhances the inhibitory effects of the cholesterol biosynthesis inhibitor RO 48-8071 on hormone-dependent breast-cancer growth.
    Liang Y; Besch-Williford C; Hyder SM
    Breast Cancer Res Treat; 2022 Feb; 192(1):53-63. PubMed ID: 35037188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of estrogenic activity of licorice species in comparison with hops used in botanicals for menopausal symptoms.
    Hajirahimkhan A; Simmler C; Yuan Y; Anderson JR; Chen SN; Nikolić D; Dietz BM; Pauli GF; van Breemen RB; Bolton JL
    PLoS One; 2013; 8(7):e67947. PubMed ID: 23874474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective estrogen receptor-beta (SERM-beta) compounds modulate raphe nuclei tryptophan hydroxylase-1 (TPH-1) mRNA expression and cause antidepressant-like effects in the forced swim test.
    Clark JA; Alves S; Gundlah C; Rocha B; Birzin ET; Cai SJ; Flick R; Hayes E; Ho K; Warrier S; Pai L; Yudkovitz J; Fleischer R; Colwell L; Li S; Wilkinson H; Schaeffer J; Wilkening R; Mattingly E; Hammond M; Rohrer SP
    Neuropharmacology; 2012 Nov; 63(6):1051-63. PubMed ID: 22796107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of liquiritigenin treatment on the learning and memory deficits induced by amyloid beta-peptide (25-35) in rats.
    Liu RT; Zou LB; Fu JY; Lu QJ
    Behav Brain Res; 2010 Jun; 210(1):24-31. PubMed ID: 20117143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective estrogen receptor modulator effects of epimedium extracts on breast cancer and uterine growth in nude mice.
    Indran IR; Zhang SJ; Zhang ZW; Sun F; Gong Y; Wang X; Li J; Erdelmeier CA; Koch E; Yong EL
    Planta Med; 2014 Jan; 80(1):22-8. PubMed ID: 24310211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anabolic effect of the traditional Chinese medicine compound tanshinone IIA on myotube hypertrophy is mediated by estrogen receptor.
    Zhao P; Soukup ST; Hegevoss J; Ngueu S; Kulling SE; Diel P
    Planta Med; 2015 May; 81(7):578-85. PubMed ID: 26018796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes.
    Cvoro A; Tatomer D; Tee MK; Zogovic T; Harris HA; Leitman DC
    J Immunol; 2008 Jan; 180(1):630-6. PubMed ID: 18097065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative in vitro metabolism of liquiritigenin, a bioactive compound isolated from the Chinese herbal selective estrogen beta-receptor agonist MF101.
    Kupfer R; Swanson L; Chow S; Staub RE; Zhang YL; Cohen I; Christians U
    Drug Metab Dispos; 2008 Nov; 36(11):2261-9. PubMed ID: 18669586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
    Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists.
    Paruthiyil S; Cvoro A; Zhao X; Wu Z; Sui Y; Staub RE; Baggett S; Herber CB; Griffin C; Tagliaferri M; Harris HA; Cohen I; Bjeldanes LF; Speed TP; Schaufele F; Leitman DC
    PLoS One; 2009 Jul; 4(7):e6271. PubMed ID: 19609440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytoestrogens from Psoralea corylifolia reveal estrogen receptor-subtype selectivity.
    Xin D; Wang H; Yang J; Su YF; Fan GW; Wang YF; Zhu Y; Gao XM
    Phytomedicine; 2010 Feb; 17(2):126-31. PubMed ID: 19577453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer.
    Chan KK; Leung TH; Chan DW; Wei N; Lau GT; Liu SS; Siu MK; Ngan HY
    J Endocrinol; 2014 May; 221(2):325-36. PubMed ID: 24819599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deoxybenzoins are novel potent selective estrogen receptor modulators.
    Papoutsi Z; Kassi E; Fokialakis N; Mitakou S; Lambrinidis G; Mikros E; Moutsatsou P
    Steroids; 2007 Sep; 72(9-10):693-704. PubMed ID: 17659312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.
    Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL
    Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.